Biotech Values

[jmkobers]

...current cash at $273 mil my thought was that they wouldn't let cash drop below $200 mil which basically gives them a 3 to 6 quarters to get there.

To me it's looking like company is aware at least one more raise will be needed - and they will give you a big song and dance after it happens on why it will be the last one. Meanwhile, they've dot plotted out the pps course with their new "partner" for raise and this partner has been shorting/maipulating the holy bejuses out of this thing as per the plan. If there is bad approval news the company surely isn't telling anyone, so IMO the price action is consistent with an August approval followed by another river of money courtesy of the street. If I am wrong I will be very wrong here but I view this as a rare opportunity. Good luck Jbog